Cravit Ophthalmic Solution/Cravit 1.5% Ophthalmic Solution Adverse Reactions

Clinically significant adverse reactions (rarely: <0.1%; occasionally: ≥0.1% to <5%; and no specific designation: ≥5% or incidence unknown): Shock, anaphylactoid reaction: Since shock and anaphylactoid reaction may occur levofloxacin ophthalmic solution, patients should be carefully observed. If any symptoms such as, erythema, rash, dyspnoea, decreased blood pressure, and eyelid oedema, etc. are observed, administration should be discontinued and appropriate measures should be taken.
Others: If the following adverse reactions are observed, appropriate measures eg, discontinuing administration, should be taken.
Cravit Ophthalmic Solution 0.5%: (See Table 3.)

Click on icon to see table/diagram/image

Cravit Ophthalmic Solution 1.5%: Adverse reactions were reported in 7 of 238 patients (2.9%) in clinical trials in Japan. The adverse reactions were eye irritation in 3 patients (1.3%), dysguesia in 2 patients (0.8%), eye itching in 1 patient (0.4%), and urticaria in 1 patient (0.4%). (At the time of approval). (See Table 4.)

Click on icon to see table/diagram/image